Extract notice to the Minister
Riva-Dapagliflozin
Common name / Subject : dapagliflozine (insuffisance cardiaque, fraction d'éjection >40%)
Name of the manufacturer : Riva
Form :
Dosage :
Name of the manufacturer : Riva
Form :
Dosage :
Indication :
INESSS' Recommendation
Inscription - Avec conditions
Minister's decisions
Inscrire aux listes des
médicaments - Médicament
d'exception
Evaluation published on April 01, 2026